Assaf Segal
Business Affairs
MediWound
Israel
Biography
Mr. Assaf Segal is currently the Chief Financial Officer at Clal Biotechnology Industries, one of Israel’s leading investment companies with a portfolio of investments in biotechnology companies in Israel and the U.S. Before joining Clal Biotechnology in 2015, Mr. Segal was a Partner at Variance Economic Consulting for 11 years. He also has experience in corporate finance at Kesselman Corporate Finance – Price Waterhouse Coopers and served as the Head of Economic Department, North American Division at Amdocs. Mr. Segal received his Master in Business Administration in Finance & Information Systems and a B.A. in Economics and Statistics from The Hebrew University in Jerusalem, Israel.
Research Interest
Business Affairs
